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High preoperative serum carcinoembryonic antigen (CEA) levels have been well investigated and
found to be associated with poor prognosis in patients with colorectal cancer (CRC). However, it
has been observed that the outcome varies after curative resection, along with postoperative serum
CEA levels; some patients continue to have high postoperative serum CEA levels while postopera-
tive CEA levels return to normal in others. The purpose of this study was to determine the prognos-
tic significance of postoperative serum CEA levels in CRC patients with high preoperative serum
CEA levels. Between January 2002 and December 2004, 423 CRC patients underwent operation in
our hospital; 181 (42.8%) had high preoperative serum CEA levels and were enrolled in this study.
Among the 181 patients, 165 patients had curative resection; the remaining 16 had stage IV disease,
so they underwent palliative surgery and were subsequently excluded from analysis. Pre- and post-
operative serum CEA levels were measured and analyzed. All patients had curative resection and
were divided into two groups according to postoperative serum CEA levels: one group comprised
patients with postoperative serum CEA ≥5 ng/mL (n=80) and the other group comprised patients
with postoperative serum CEA levels < 5 ng/mL (n=85). Postoperative serum CEA levels were sig-
nificantly related to location of primary tumors (p=0.042), lymph node metastases (p=0.009), TNM
stage (p=0.001), and postoperative relapse (p=0.004). The results of multivariate analysis showed
that both lymph node metastases and high postoperative serum CEA levels (≥5 ng/mL) were inde-
pendent prognostic factors for CRC patients after curative resection. Postoperative serum CEA
levels can be a single independent prognostic determinant in CRC patients with high preoperative
serum CEA levels. Intensive follow-up and adjuvant therapy may be necessary in CRC patients
who continue to have high postoperative serum CEA levels even after curative resection.
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Carcinoembryonic antigen (CEA) is an intracellular
protein that normally exists in the embryonic and
fetal gut, liver, pancreas, and some adult organs [1]. It
is elevated in approximately 40% of colorectal cancers
(CRCs) [2] and is the most commonly applied tumor
marker in CRCs since it was first mentioned in 1965 [3].
CEA has been well investigated, and it has been
demonstrated that CRC patients with high preopera-
tive serum CEA levels are associated with an advanced
tumor stage, incidence of recurrence and survival 
[2,4–11]. However, prognosis varies in patients with
high preoperative serum CEA levels after curative
surgery; meanwhile, CEA levels differ after curative
surgery as well. Among CRC patients with high pre-
operative serum CEA levels, there should be some
factors that can be used to predict the outcome.
In this study, we retrospectively analyzed stage
I–III CRC patients with high preoperative serum CEA
levels, and postoperative serum CEA levels were also
measured and analyzed after curative surgery.
MATERIALS AND METHODS
Patients
Between January 2002 and December 2004, 423 CRC
patients underwent operation in our hospital, of whom
181 (42.8%) had preoperative CEA levels ≥ 5 ng/mL
and were included in this study. Among the 181
patients, 165 underwent curative resection; the remain-
ing 16 patients had stage IV disease, so they underwent
palliative surgery and were subsequently excluded
from analysis.
Preoperative serum CEA was sampled within 
1 week before operation, and postoperative serum
CEA was obtained at least 4 weeks after operation
[12]. Serum CEA levels were determined by means of
an enzyme immunoassay test kit (DPC Diagnostic
Product Co., Los Angeles, CA, USA) with the upper
limit of normal set at 5 ng/mL according to the man-
ufacturer’s instructions.
Statistical analysis
All data were analyzed using SPSS version 11.5 (SPSS
Inc., Chicago, IL, USA). The χ2 test was used to com-
pare the clinicopathologic parameters between groups
with postoperative serum CEA levels ≥ 5 ng/mL
and postoperative serum CEA levels < 5 ng/mL. The
cumulative survival rates were calculated by the
Kaplan–Meier method, and the differences in survival
rates were analyzed by log-rank test. The multivari-
ate analysis of independent prognostic factors for post-
operative relapse was determined using multivariate
logistic regression analysis. A probability of p < 0.05
was considered to be statistically significant.
RESULTS
Of the 165 patients included in the analysis, 81 were
male and 84 were female, mean age was 67.4 years
(range, 27–93 years), and the median period of follow-
up was 28 months (range, 12–48 months). Eight (4.8%)
patients had stage I disease, 79 (47.9%) had stage II,
and 78 (47.3%) had stage III disease. The clinicopatho-
logic characteristics of the patients are summarized
in Table 1.
In CRC patients with abnormal preoperative serum
CEA levels, serum CEA remained high after curative
Table 1. Demographic and clinical characteristics of
colorectal cancer patients with high preoperative carci-
noembryonic antigen levels
Patients, n
Total cases 165
Age, yr (mean ± SD) 67.4 ± 13.5
< 60/≥ 60 38/127
Sex
Male/female 81/84
Tumor size, cm
< 5/≥ 5 80/85
Location
Colon/rectum 120/45
Histologic type
Well/moderate/poor 17/121/27
Depth of tumor invasion
T1/T2/T3/T4 3/6/145/11
Lymph node metastases
N0/N1/N2 87/44/34
Tumor node metastasis stage
I/II/III 8/79/78
Vessel involvement
Absent/present 77/88
Perineurial involvement
Absent/present 86/79
Postoperative metastasis
Absent/present 97/68
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resection in some patients, but returned to normal in
other patients. This result was further divided into
two groups according to postoperative serum CEA
levels: ≥ 5 ng/mL (high CEA group) and < 5 ng/mL
(low CEA group). There were 80 (48.5%) patients
with postoperative serum CEA levels ≥ 5 ng/mL and
85 (51.5%) with postoperative serum CEA levels
< 5 ng/mL. Overall, the incidence of postoperative
serum CEA levels ≥ 5 ng/mL was 18.9% (of 423 CRC
patients).
Postoperative serum CEA levels were related to
the location of primary tumors (p=0.042), lymph node
Table 2. Clinicopathologic features and postoperative carcinoembryonic antigen (CEA) levels in 165 patients with
pathologic stage I–III colorectal cancer
Postoperative CEA level
p
≥ 5 ng/mL (n = 80) < 5 ng/mL (n = 85)
Age, yr 0.186
< 60 22 16
≥ 60 58 69
Gender 0.395
Male 42 39
Female 38 46
Tumor size, cm 0.385
< 5 36 44
≥ 5 44 41
Location 0.042
Colon 64 56
Rectum 16 29
Histologic type 0.656
Well 9 8
Moderate 60 61
Poor 11 16
Depth of tumor invasion 0.801
T1 1 2
T2 2 4
T3 71 74
T4 6 5
Lymph node metastasis 0.009
N0 33 54
N1 24 20
N2 23 11
TNM stage* 0.001
I 3 5
II 27 52
III 50 28
Vessel involvement 0.298
Absent 34 43
Present 46 42
Perineurial permeation 0.597
Absent 40 46
Present 40 39
Postoperative relapse 0.004
Absent 38 59
Present 42 26
*According to the 6th edition of the TNM classification. TNM = tumor node metastasis.
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metastases (p = 0.009), tumor node metastasis (TNM)
stage (p = 0.001), and postoperative relapse (p = 0.004).
They did not differ significantly with respect to age,
gender, tumor size, histologic type, invasion depth,
vessel involvement, and perineurial permeation (Table
2). Meanwhile, the overall survival rate of the two
groups was significantly different (p=0.0131). Patients
in the low postoperative serum CEA group had a better
overall survival rate than those in the high postoper-
ative serum CEA group (Figure). Multivariate analy-
sis of the variables listed in Table 2 showed that both
lymph node metastases (p = 0.028) and high postoper-
ative serum CEA levels (p = 0.006) were independent
prognostic factors (Table 3).
DISCUSSION
It has been reported that high preoperative serum CEA
levels are associated with a poor prognosis [2,4,9,11,13].
However, the prognostic significance of postoperative
serum CEA levels have seldom been discussed or
investigated. Postoperatively, some CRC patients con-
tinue to have high serum CEA levels, whereas others
have serum CEA levels return to within a normal
range. The differences can be attributed to several fac-
tors. We found that the location of the primary tumor,
lymph node metastases, and TNM stage were signifi-
cantly related to high postoperative serum CEA levels.
The higher incidence of postoperative serum CEA lev-
els in the colon than in the rectum may be associated
with the increased incidence of distant metastases in
patients with colon cancer and even greater incidence
of local recurrence in those with rectal cancer [14],
although the exact reasons are unclear and require fur-
ther investigation. In addition, postoperative serum
CEA levels ≥5ng/mL were significantly correlated with
the presence of lymph node metastases, more advanced
tumor stage, and postoperative relapse. Lymph node
metastases, together with advanced TNM stage, are
well known to be associated with prognosis and deter-
mine the treatment modality, such as adjuvant chemo-
therapy. Concurrently, high postoperative serum CEA
levels are also related to postoperative relapse, espe-
cially liver metastases in previous investigations [13,15],
which may also contribute to the prognosis. Slentz et al
also suggested that an initially elevated CEA level that
fails to fall to normal in the early postoperative period
following curative resection may represent an addi-
tional relevant risk factor [16]. Therefore, consideration
of prognosis should include postoperative serum CEA
levels and TNM stage.
The current investigation found that 48.5% of
CRC patients with abnormal preoperative serum CEA
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Figure. Cumulative overall survival rates of patients with colo-
rectal cancer analyzed according to pre- and postoperative serum
carcinoembryonic antigen (CEA) levels. Patients whose abnormal
preoperative value did not return to normal were found to have a
worse overall survival (p = 0.0131).
Table 3. Factors significantly associated with postoperative relapse in colorectal cancer patients on multivariate logis-
tic regression analysis
β SE p OR 95% CI
Lymph node metastasis
(Present/absent) 0.906 0.413 0.028 2.474 1.101–5.556
Postoperative CEA levels
(≥ 5 ng/mL/< 5 ng/mL) 1.151 0.416 0.006 3.161 1.400–7.140
β = coefficient; SE = standard error; OR = odds ratio; CI = confidence interval; CEA = carcinoembryonic antigen.
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continued to have high serum CEA postoperatively.
Furthermore, the results of multivariate analysis indi-
cated that both lymph node metastases and postop-
erative serum CEA levels are independent prognostic
factors in CRC patients with abnormal levels of pre-
operative serum CEA. High postoperative serum
CEA levels seem to be more powerful than lymph
node metastases in predicting prognosis, with a rela-
tive risk of 3.161. Although high preoperative serum
CEA levels were demonstrated to be associated with
an inferior clinical outcome, postoperative serum CEA
levels returning to normal predict a better prognosis
[16,17]. Moreover, patients who continue to have high
postoperative serum CEA may require more intensive
follow-up and treatment, even in patients with stage I
or II disease for which adjuvant chemotherapy is
conventionally considered unnecessary or controver-
sial [18–20]. However, this presumption needs fur-
ther investigation in a larger patient population with
long-term follow-up.
In conclusion, the measurement of postoperative
serum CEA levels in CRC patients with abnormal pre-
operative serum CEA levels after curative resection is
potentially beneficial in clinical practice. The failure of
conversion of abnormal preoperative serum CEA level
to normal is an important indicator of poor prognosis.
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